Research Article

Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum Metabolomics

Table 3

Potential differential metabolites between the NC group and the DM group.

MetabolitesFormulaHMDBm/zRetention time (min)Change

UridineC9H12N2O6HMDB00296243.061.75
Vitamin K2C41H56O2HMDB30017625.429.85
L-AcetylcarnitineC9H17NO4HMDB00201202.114.33
Prostaglandin F1aC20H36O5HMDB02685377.234.94
L-PalmitoylcarnitineC23H45NO4HMDB00222436.286.25
5-Hydroxy-N-formylkynurenineC11H12N2O5HMDB04086287.051.93
Prostaglandin H2C20H32O5HMDB01381351.224.94
dUMPC9H13N2O8PHMDB01409307.031.3
Leukotriene A4C20H30O3HMDB01337317.216.05
Gamma-tocotrienolC28H42O2HMDB12958409.316.57
Phosphatidylcholine (20:4(5Z,8Z,11Z,14Z)/18:0)C46H84NO8PHMDB08431854.5923.43
Taurocholic acidC26H45NO7SHMDB00036514.284.7
GlcCer (d18:1/16:0)C40H77NO8HMDB04971736.5221.72
Phosphatidyl ethanolamine (20:2(11Z,14Z)/16:1(9Z))C41H76NO8PHMDB09287786.536.18
Deoxythymidine diphosphate-l-rhamnoseC16H26N2O15P2HMDB06354529.064.49
Pyridoxine -phosphateC8H12NO6PHMDB01319497.074.27
L-TryptophanC11H12N2O2HMDB00929453.185.06
L-CarnitineC7H15NO3HMDB00062381.235.39
Phosphatidylcholine (16:0/0:0)C24H50NO7PHMDB10382530.36.62
Allodeoxycholic acidC24H40O4HMDB00478391.285.69
XanthosineC10H12N4O6HMDB00299283.072.16
Alpha-lactoseC12H22O11HMDB00186377.090.92
3a,7a-Dihydroxy-5b-cholestaneC27H48O2HMDB06893449.3622
Glycochenodeoxycholic acid 3-glucuronideC32H51NO11HMDB02579660.315.29
L-Lactic acidC3H6O3HMDB0019089.021.28
Retinyl esterC20H30O2HMDB03598301.225.46